Trevi Therapeutics Inc (TRVI)
2.64
-0.26
(-8.97%)
USD |
NASDAQ |
May 08, 16:00
2.64
0.00 (0.00%)
Pre-Market: 20:00
Trevi Therapeutics Shareholders Equity (Quarterly): 82.55M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 82.55M |
| September 30, 2023 | 89.61M |
| June 30, 2023 | 95.07M |
| March 31, 2023 | 101.73M |
| December 31, 2022 | 107.46M |
| September 30, 2022 | 109.90M |
| June 30, 2022 | 60.52M |
| March 31, 2022 | 10.46M |
| December 31, 2021 | 17.08M |
| September 30, 2021 | 11.38M |
| June 30, 2021 | 17.74M |
| Date | Value |
|---|---|
| March 31, 2021 | 23.68M |
| December 31, 2020 | 27.28M |
| September 30, 2020 | 35.62M |
| June 30, 2020 | 40.04M |
| March 31, 2020 | 46.80M |
| December 31, 2019 | 54.54M |
| September 30, 2019 | 60.71M |
| June 30, 2019 | 67.70M |
| March 31, 2019 | 12.68M |
| December 31, 2018 | 6.248M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.46M
Minimum
Mar 2022
109.90M
Maximum
Sep 2022
55.78M
Average
54.54M
Median
Dec 2019
Shareholders Equity (Quarterly) Benchmarks
| Accuray Inc | 41.08M |
| Vanda Pharmaceuticals Inc | 544.91M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 89.40M |
| Total Liabilities (Quarterly) | 6.856M |